Theravance Biopharma (TBPH) Raw Materials (2013 - 2018)
Theravance Biopharma (TBPH) posted Raw Materials of $10.79 million for Q3 2018, up 8.4% from $9.95 million a year earlier and up 1.9% from the prior quarter.
Powered by 
Analysis
Theravance Biopharma (TBPH) Raw Materials (2013 - 2018) Analysis & Trends
At the end of FY2017, Theravance Biopharma's Raw Materials came in at $11.73 million, up 93.3% from FY2016.
- Annual Raw Materials shows a four-year compound annual growth rate of 22.9% (FY2013 to FY2017).
- In prior years, Theravance Biopharma's Raw Materials was $6.07 million in FY2016 (-11.7%), $6.87 million in FY2015 (+0.6%), $6.83 million in FY2014 (+32.9%) and $5.14 million in FY2013.
- Quarterly Raw Materials has run from a low of $4 million in Q1 2014 to a high of $11.73 million in Q4 2017 over five years.
- On a year-over-year basis, Raw Materials has increased in each of the last seven quarters, with growth averaging 35.4% over the last eight quarters.
- The strongest year-over-year quarter for Raw Materials in the past five years was Q4 2017, with growth of 93.3%; the weakest was Q1 2016, with a decline of 21.9%.
- According to Business Quant data, Raw Materials for the three prior quarters was $10.58 million (Q2 2018), $10.61 million (Q1 2018) and $11.73 million (Q4 2017).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2018 | 10.79 Mn |
| Jun 30, 2018 | 10.58 Mn |
| Mar 31, 2018 | 10.61 Mn |
| Dec 31, 2017 | 11.73 Mn |
| Sep 30, 2017 | 9.95 Mn |
| Jun 30, 2017 | 6.75 Mn |
| Mar 31, 2017 | 7.44 Mn |
| Dec 31, 2016 | 6.07 Mn |
| Sep 30, 2016 | 7.29 Mn |
| Jun 30, 2016 | 5.81 Mn |
| Mar 31, 2016 | 5.27 Mn |
| Dec 31, 2015 | 6.87 Mn |
| Sep 30, 2015 | 7.31 Mn |
| Jun 30, 2015 | 7.31 Mn |
| Mar 31, 2015 | 6.75 Mn |
| Dec 31, 2014 | 6.83 Mn |
| Sep 30, 2014 | 6.83 Mn |
| Jun 30, 2014 | 6.86 Mn |
| Mar 31, 2014 | 4.00 Mn |
| Dec 31, 2013 | 5.14 Mn |
API Access
Theravance Biopharma Raw Materials API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=raw-materials&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "raw-materials", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=raw-materials&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();